PIAS4

PIAS4

Protein inhibitor of activated STAT, 4, also known as PIAS4, is a human gene. [cite web | title = Entrez Gene: PIAS4 Protein inhibitor of activated STAT, 4| url = http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=51588| accessdate = ]

PBB_Summary
section_title =
summary_text =

References

Further reading

PBB_Further_reading
citations =
*cite journal | author=Maruyama K, Sugano S |title=Oligo-capping: a simple method to replace the cap structure of eukaryotic mRNAs with oligoribonucleotides. |journal=Gene |volume=138 |issue= 1-2 |pages= 171–4 |year= 1994 |pmid= 8125298 |doi=
*cite journal | author=Suzuki Y, Yoshitomo-Nakagawa K, Maruyama K, "et al." |title=Construction and characterization of a full length-enriched and a 5'-end-enriched cDNA library. |journal=Gene |volume=200 |issue= 1-2 |pages= 149–56 |year= 1997 |pmid= 9373149 |doi=
*cite journal | author=Liu B, Liao J, Rao X, "et al." |title=Inhibition of Stat1-mediated gene activation by PIAS1. |journal=Proc. Natl. Acad. Sci. U.S.A. |volume=95 |issue= 18 |pages= 10626–31 |year= 1998 |pmid= 9724754 |doi=
*cite journal | author=Liu B, Gross M, ten Hoeve J, Shuai K |title=A transcriptional corepressor of Stat1 with an essential LXXLL signature motif. |journal=Proc. Natl. Acad. Sci. U.S.A. |volume=98 |issue= 6 |pages= 3203–7 |year= 2001 |pmid= 11248056 |doi= 10.1073/pnas.051489598
*cite journal | author=Nelson V, Davis GE, Maxwell SA |title=A putative protein inhibitor of activated STAT (PIASy) interacts with p53 and inhibits p53-mediated transactivation but not apoptosis. |journal=Apoptosis |volume=6 |issue= 3 |pages= 221–34 |year= 2001 |pmid= 11388671 |doi=
*cite journal | author=Gross M, Liu B, Tan J, "et al." |title=Distinct effects of PIAS proteins on androgen-mediated gene activation in prostate cancer cells. |journal=Oncogene |volume=20 |issue= 29 |pages= 3880–7 |year= 2001 |pmid= 11439351 |doi= 10.1038/sj.onc.1204489
*cite journal | author=Sachdev S, Bruhn L, Sieber H, "et al." |title=PIASy, a nuclear matrix-associated SUMO E3 ligase, represses LEF1 activity by sequestration into nuclear bodies. |journal=Genes Dev. |volume=15 |issue= 23 |pages= 3088–103 |year= 2001 |pmid= 11731474 |doi=
*cite journal | author=Ohmine K, Ota J, Ueda M, "et al." |title=Characterization of stage progression in chronic myeloid leukemia by DNA microarray with purified hematopoietic stem cells. |journal=Oncogene |volume=20 |issue= 57 |pages= 8249–57 |year= 2002 |pmid= 11781839 |doi= 10.1038/sj.onc.1205029
*cite journal | author=Tan JA, Hall SH, Hamil KG, "et al." |title=Protein inhibitors of activated STAT resemble scaffold attachment factors and function as interacting nuclear receptor coregulators. |journal=J. Biol. Chem. |volume=277 |issue= 19 |pages= 16993–7001 |year= 2002 |pmid= 11877418 |doi= 10.1074/jbc.M109217200
*cite journal | author=Strausberg RL, Feingold EA, Grouse LH, "et al." |title=Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences. |journal=Proc. Natl. Acad. Sci. U.S.A. |volume=99 |issue= 26 |pages= 16899–903 |year= 2003 |pmid= 12477932 |doi= 10.1073/pnas.242603899
*cite journal | author=Subramanian L, Benson MD, Iñiguez-Lluhí JA |title=A synergy control motif within the attenuator domain of CCAAT/enhancer-binding protein alpha inhibits transcriptional synergy through its PIASy-enhanced modification by SUMO-1 or SUMO-3. |journal=J. Biol. Chem. |volume=278 |issue= 11 |pages= 9134–41 |year= 2003 |pmid= 12511558 |doi= 10.1074/jbc.M210440200
*cite journal | author=Dahle Ø, Andersen TØ, Nordgård O, "et al." |title=Transactivation properties of c-Myb are critically dependent on two SUMO-1 acceptor sites that are conjugated in a PIASy enhanced manner. |journal=Eur. J. Biochem. |volume=270 |issue= 6 |pages= 1338–48 |year= 2003 |pmid= 12631292 |doi=
*cite journal | author=Yamamoto H, Ihara M, Matsuura Y, Kikuchi A |title=Sumoylation is involved in beta-catenin-dependent activation of Tcf-4. |journal=EMBO J. |volume=22 |issue= 9 |pages= 2047–59 |year= 2003 |pmid= 12727872 |doi= 10.1093/emboj/cdg204
*cite journal | author=Lee PS, Chang C, Liu D, Derynck R |title=Sumoylation of Smad4, the common Smad mediator of transforming growth factor-beta family signaling. |journal=J. Biol. Chem. |volume=278 |issue= 30 |pages= 27853–63 |year= 2003 |pmid= 12740389 |doi= 10.1074/jbc.M301755200
*cite journal | author=Chun TH, Itoh H, Subramanian L, "et al." |title=Modification of GATA-2 transcriptional activity in endothelial cells by the SUMO E3 ligase PIASy. |journal=Circ. Res. |volume=92 |issue= 11 |pages= 1201–8 |year= 2003 |pmid= 12750312 |doi= 10.1161/01.RES.0000076893.70898.36
*cite journal | author=Imoto S, Sugiyama K, Muromoto R, "et al." |title=Regulation of transforming growth factor-beta signaling by protein inhibitor of activated STAT, PIASy through Smad3. |journal=J. Biol. Chem. |volume=278 |issue= 36 |pages= 34253–8 |year= 2003 |pmid= 12815042 |doi= 10.1074/jbc.M304961200
*cite journal | author=Galleguillos D, Vecchiola A, Fuentealba JA, "et al." |title=PIASgamma represses the transcriptional activation induced by the nuclear receptor Nurr1. |journal=J. Biol. Chem. |volume=279 |issue= 3 |pages= 2005–11 |year= 2004 |pmid= 14559918 |doi= 10.1074/jbc.M308113200
*cite journal | author=Gross M, Yang R, Top I, "et al." |title=PIASy-mediated repression of the androgen receptor is independent of sumoylation. |journal=Oncogene |volume=23 |issue= 17 |pages= 3059–66 |year= 2004 |pmid= 14981544 |doi= 10.1038/sj.onc.1207443
*cite journal | author=Zoumpoulidou G, Jones MC, Fernandez de Mattos S, "et al." |title=Convergence of interferon-gamma and progesterone signaling pathways in human endometrium: role of PIASy (protein inhibitor of activated signal transducer and activator of transcription-y). |journal=Mol. Endocrinol. |volume=18 |issue= 8 |pages= 1988–99 |year= 2005 |pmid= 15155784 |doi= 10.1210/me.2003-0467
*cite journal | author=Imoto S, Sugiyama K, Yamamoto T, Matsuda T |title=The RING domain of PIASy is involved in the suppression of bone morphogenetic protein-signaling pathway. |journal=Biochem. Biophys. Res. Commun. |volume=319 |issue= 1 |pages= 275–82 |year= 2004 |pmid= 15158472 |doi= 10.1016/j.bbrc.2004.04.161

PBB_Controls
update_page = yes
require_manual_inspection = no
update_protein_box = yes
update_summary = yes
update_citations = yes


Wikimedia Foundation. 2010.

Игры ⚽ Нужно решить контрольную?

Look at other dictionaries:

  • SUMO network — consists of enzymes and substrates involved in the dynamic posttranslational modification process of sumoylation (i.e. transfer of SUMO protein to substrates). Network membersThe SUMO network members (gene name and aliases) as published in the… …   Wikipedia

  • Mothers against decapentaplegic homolog 6 — SMAD family member 6 Identifiers Symbols SMAD6; HsT17432; MADH6; MADH7 External IDs …   Wikipedia

  • Mothers against decapentaplegic homolog 7 — SMAD family member 7 Solution Structure Of Smurf2 Ww3 Domain Smad7 Py Peptide Complex Identifiers Symbols …   Wikipedia

  • Type I cytokine receptor — Type I cytokine receptors are transmembrane receptors expressed on the surface of cells that recognize and respond to cytokines with four α helical strands. These receptors are also known under the name hemopoietin receptors, and share a common… …   Wikipedia

  • PIAS protein — PIAS (Protein Inhibitors of Activated STAT) refers to a family of genes involved in inhibiting the JAK STAT signaling pathway.Genes* PIAS1 * PIAS2 * PIAS3 * PIAS4External links* …   Wikipedia

  • SOCS3 — Suppressor of cytokine signaling 3 PDB rendering based on 2bbu …   Wikipedia

  • Suppressor of cytokine signaling 1 — Identifiers Symbols SOCS1; CIS1; CISH1; JAB; SOCS 1; SSI 1; SSI1; TIP3 External IDs …   Wikipedia

Share the article and excerpts

Direct link
Do a right-click on the link above
and select “Copy Link”